Data / Form D filings / CENERX BIOPHARMA INC
CENERX BIOPHARMA INC: Form D filings
CENERX BIOPHARMA INC, a biotechnology company in Cary, NC, filed 7 Form D notices with the SEC between 2009 and 2012. The latest, on June 15, 2012, reports $5.2 million sold of a $5.2 million offering to 7 investors.
Find out what CENERX BIOPHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 270 CORNERSTONE DR, SUITE 103, Cary, NC, 27519
- Phone
- (919) 523-0489
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1344759
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2012 | Amendment | $5,153,674 | $5,153,674 | $0 | 7 | Nov 21, 2011 | sec.gov |
| Nov 30, 2011 | New notice | $4,850,000 | $4,616,674 | $233,326 | 6 | Nov 21, 2011 | sec.gov |
| Jan 10, 2011 | Amendment | $7,000,000 | $7,000,000 | $0 | 5 | Aug 5, 2010 | sec.gov |
| Dec 9, 2010 | Amendment | $6,000,000 | $6,000,000 | $0 | 5 | Aug 5, 2010 | sec.gov |
| Aug 11, 2010 | New notice | $3,000,000 | $3,000,000 | $0 | 5 | Aug 5, 2010 | sec.gov |
| Jan 19, 2010 | New notice | $3,500,000 | $3,500,000 | $0 | 5 | Jan 11, 2010 | sec.gov |
| Jun 16, 2009 | New notice | $4,000,001 | $4,000,001 | $0 | 5 | Jun 10, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anthony Sun | Director | |
| Steven Elms | Director | |
| Mark Baric | Executive Officer, Director | |
| Barry Brand | Executive Officer, Director | |
| Arthur Pappas | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jun 11, 2012 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CENERX BIOPHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.